NYSE:AIM

Aim Immunotech Stock Predictions

Healthcare > Biotechnology

Buy AIM

*Your capital is at risk

$0.732

-0.0947 (-11.46%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

AIM Prediction Chart

AIM Predictions History

Latest community submissions for AIM.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Feb 11, 2021	$2.72 +3.86%	$2.70	X	99.26%	4
Dominik_509 @Dominik_509.206175	Feb 11, 2021	Bullish	$2.70	V	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AIM with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT AIM IMMUNOTECH INC.

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, n...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by